ASCO Classic Oncology References. Colorectal Cancer. General References. 1.
Alberts DS, Martinez MA, Roe DJ, et al. Lack of Effect of a High-Fiber Cereal ...
ASCO Classic Oncology References Colorectal Cancer
General References 1. Alberts DS, Martinez MA, Roe DJ, et al. Lack of Effect of a High-Fiber Cereal Supplement on the Recurrence of Colorectal Adenomas. New England Journal Med; 2000; 342: 1156 1162 Full Text 2. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. New England Journal Med; 2000; 343(3): 162- 8 Full Text 3. Gryfe R, Kim H, Hsieh ETK, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. New England Journal Med; 2000; 342: 69-77 Full Text 4. Desch CE, Benson AB III, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Soceity of Clinical Oncology. Journal Clinical Oncology; 1999; 17 (4); 1312-1321 Full Text 5. Lange CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy? JAMA; 1994; 271 (13):1011-1013 View Abstract 6. Mandel JS, Bond JH, Church TR, et al, Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New England Journal Med; 1993; 328 (19); 1365- 71 Full Text 7. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New England Journal Med; 1993; 329 (27); 1977- 81 Full Text 8. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. New England Journal Medicine; 1993; 328 (13): 901- 6. Full Text
Epidemiology/Biology 1. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New England Journal Med; 1998; 338(21): 1481-7 Full Text 2. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et at. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. Journal Clinical Oncology. 1998; 16(2): 427-433 Full Text 3. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. New England Journal Med; 1990; 323 (18): 1228- 33 Full Text
Neo Adjuvant/Adjuvant 1. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696704, 2005 Full Text 2. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-51, 2004 Full Text 3. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-47, 2000 Full Text 4. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. Journal Clinical Oncology; 17 (5): 1356; 1999 Full Text 5. O’Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. Journal Clinical Oncology; 15: 246-250; 1997 Full Text 6. International Mutlicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. The Lancet345; 939-944; 1995 View Abstract 7. O’Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery. New England Journal Med; 331 (8): 502-507; 1994 Full Text 8. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Journal Clinical Oncology; 10: 896-903; 1992 Full Text
Local Therapy 1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-46, 2001 Full Text 2. Wolmark N, Wieand S, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. Journal National Cancer Inst 92;388-396; 2000 Full Text
Recurrent/Metastatic Disease 1. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337-45, 2004 Full Text 2. Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004 Full Text 3. Hurwitz H, Fehrenbacher L, Novotny W, et al, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-42, 2004 Full Text 4. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer. New England Journal Med 2000; 343: 905-914 Full Text 5. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as firstline treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041-7, 2000 View Abstract 6. Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet; 1998; 352 (9138); 1413 – 8 View Abstract 7. Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Journal Clinical Oncology; 16; 301-308; 1998 Full Text 8. Meta-analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Journal National Cancer Inst; 1996; 88; 252-258 Full Text
Special Recognition to the ASCO Career Development & Oncology Training Programs Subcommittees for their effort in developing and maintaining this resource Please send questions, comments, and feedback to
[email protected]
